Evaluation of transplantation sites for human intestinal organoids
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Aug 2020 · 1 min read
In brief
In brief
This study compares two transplantation sites for human intestinal organoids derived from embryonic stem cells: renal subcapsular space versus mesentery. While mesenteric transplantation showed higher mortality but better engraftment rates with fewer lumens, both sites produced similar tissue quality and differentiation markers after 10 weeks.
Written by the GCMD Library team from the article.
Statements in this article
Human intestinal organoids can be transplanted into either the renal subcapsular space or the mesentery for engraftment studies.
Ten weeks are allowed for engraftment and differentiation of transplanted human intestinal organoids before harvest and assessment.
Mortality is significantly increased when transplanting human intestinal organoids into the mesentery compared to the renal subcapsular space.
Engraftment rate is significantly higher for mesenteric transplantation compared to renal subcapsular transplantation.
Graft sizes are similar between renal subcapsular and mesenteric transplantation sites.
Mesenteric transplanted human intestinal organoids present with significantly fewer lumens than renal subcapsular transplanted organoids.
Expression of markers specific to epithelial differentiation, mesenchymal differentiation, and carbohydrate metabolism are similar between renal subcapsular and mesenteric transplantation sites.
Both transplantation sites yield viable tissue of similar quality based on morphometric and molecular assessments.
